Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer: A meta-analysis of randomized controlled trials
Conclusions:
Tasquinimod is associated with better rPFS in mCRPC. The toxicity of tasquinimod requires further investigation, it is not recommended for routine clinical use.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
More News: Anemia | Back Pain | Cancer | Cancer & Oncology | Clinical Trials | Databases & Libraries | Insomnia | Internal Medicine | Men | Oral Cancer | Pain | Prostate Cancer | Study | Toxicology